News | Prostate Cancer | February 18, 2016

Cancer institute will investigate use of Senior Scientific’s magnetic relaxometry technology for detection and diagnosis

Weill Cornell Medicine, Senior Scientific, magnetix relaxometry, MRX technology, prostate cancer detection

February 18, 2016 — Manhattan Scientifics Inc. announced its wholly-owned subsidiary Senior Scientific LLC, which is developing a platform for the early detection of cancer and other human diseases, has established a research collaboration with Weill Cornell Medicine. For the alliance, the company will bring its magnetic relaxometry technology to Weill Cornell Medicine, where scientists will investigate the use of molecularly targeted nanoparticles to non-invasively detect and diagnose prostate cancers.

“We have extensive experience in targeting radionuclides to cancer for imaging and therapy using antibodies and small molecules,” said John Babich, Ph.D., professor of radiopharmaceutical sciences in radiology at Weill Cornell Medicine. “This collaboration enables us to leverage our expertise in prostate cancer targeting to explore Senior Scientific’s non-radioactive magnetic nanoparticle platform for early detection of cancer.”

Gary Dorfman, M.D., vice chairman for research at the Weill Cornell Medicine Department of Radiology and professor of radiology, added, “The MRX technology may have advantages for patient care compared to PET [positron emission tomography, CT [computed tomography or MRI [magnetic resonance imaging] methods, and we are looking forward to working with Senior Scientific to investigate the diagnostic applications of this technology for patients.”

On Jan. 13, 2016, the company announced it would be working with the University of Michigan Medical School on a breast cancer program, adding to its existing ovarian cancer program with the MD Anderson Cancer Center. With the addition of Weill Cornell Medicine focusing on prostate cancer, the company has engaged with three pre-eminent U.S. cancer institutes to develop commercial applications of its magnetic relaxometry platform. Each of the three institutions will have the MRX technology on-site, enabling them to undertake the pre-clinical animal model studies necessary in anticipation of first-in-human testing.

For more information: www.seniorscientific.com

Related Content

News | Magnetic Resonance Imaging (MRI)

November 24, 2021 — Royal Philips announced new AI-enabled innovations in MR imaging launching at the Radiological ...

Time November 24, 2021
arrow
News | Magnetic Resonance Imaging (MRI)

November 23, 2021 — Researchers at Yale University analyzing specialized MRI exams found significant changes in the ...

Time November 23, 2021
arrow
News | Nuclear Imaging

November 22, 2021 — IBA, a leader in particle accelerator technology, and NorthStar Medical Radioisotopes LLC, a global ...

Time November 22, 2021
arrow
News | Magnetic Resonance Imaging (MRI)

November 22, 2021 — Adolescents and young adults with post-concussive symptoms who suffered three to five concussions ...

Time November 22, 2021
arrow
Videos | Radiopharmaceuticals and Tracers

Ana Kiess, M.D., Ph.D., assistant professor of radiation oncology and molecular radiation sciences, Johns Hopkins ...

Time November 17, 2021
arrow
News | Magnetic Resonance Imaging (MRI)

November 17, 2021 — The University of Michigan Health System recently became the first U.S. healthcare institution to ...

Time November 17, 2021
arrow
News | Prostate Cancer

November 16, 2021 — A new Harvey L. Neiman Health Policy Institute study of nearly 800,000 men found that between 2011 ...

Time November 16, 2021
arrow
Videos | Radiation Oncology

Walter Curran, Jr. M.D., FACR, FASCO, GenesisCare global chief medical officer, discusses three technologies that are ...

Time November 16, 2021
arrow
News | Digital Pathology

November 15, 2021 — Saltus Biotech, a leader in 8k image technology, introduces a new high-end computer workstation and ...

Time November 15, 2021
arrow
Videos | Radiation Therapy

Siemens and Philips demonstrated examples of new imaging software to convert MRI datasets into synthetic computed ...

Time November 15, 2021
arrow
Subscribe Now